Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage.
Gingival enlargement due to the immunosuppressive drug, cyclosporin A (CsA), will resolve following discontinuation of drug therapy or extraction of adjacent teeth. This report presents a clinical observation on a patient in whom CsA-induced gingival enlargement failed to resolve with improved plaque control and scaling, but resolved quickly following reduction in the daily dosage of CsA. Despite less than optimal plaque control, the CsA-induced gingival enlargement did not recur on the reduced drug dosage over a 2-year observation period. This finding raises the possibility that reduction of CsA dosage below a certain critical level may lead to resolution of CsA-induced gingival enlargement.
Daly
C G
CG
Department of Dentistry and Oral Medicine, Royal Newcastle Hospital, NSW, Australia.
D000368:Aged; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects*; D003773:Dental Plaque / Q000517:prevention & control; D005260:Female; D005885:Gingival Hyperplasia / Q000139:chemically induced* / Q000517:prevention & control*; D005891:Gingivitis / Q000517:prevention & control; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans
D016572:Cyclosporine